Trending News
News
News
Core Site-Moiety Maps Reveal Inhibitors and Binding Mechanisms of Orthologous Proteins by Screening Compound Libraries
Study reveals the CoreSiMMap is useful to identify adaptive SK inhibitors and provide insight into the binding mechanisms of compounds.
News
Verona Pharma Appoints Manchester Clinical Research Facility to Carry Out Clinical Trial with RPL554
Enrollment of patients to start Q2, with results expected early Q4 2012.
News
Lipid Therapeutics Licenses European Rights to LT-02 for Ulcerative Colitis
Dr. Falk Pharma GmbH to initiate Phase III trial.
News
CiToxLAB Increases Inhalation Test Capabilities in North America and Europe
Growth in capacity and capabilities sees CiToxLAB emerge as a major player in the safety assessment of pharmaceuticals and chemicals via the inhalation route.
News
Macro-to-Micro Structural Proteomics: Native Source Proteins for High-Throughput Crystallization
In this study, researchers from University of California demonstrate the utility of native source proteins for high-throughput crystallography.
News
Motion and Flexibility in Human Cytochrome p450 Aromatase
X-ray structures of human placental aromatase do not provide accounts of movements in this work, researchers conduct normal mode analysis revealing the intrinsic fluctuations of aromatase.
News
Global Patterns of Genetic Diversity and Signals of Natural Selection for Human ADME Genes
This study is the first to systematically investigate worldwide population differentiation and potential signals of natural selection in a comprehensive list of ADME genes.
News
ACADIA Pharmaceuticals Extends Drug Discovery Collaboration with Allergan, Inc.
The collaboration is currently focused on the discovery of new therapeutics for glaucoma and other ophthalmic indications and was originally established in March 2003.
News
A High-Throughput Screen Identifies a New Natural Product with Broad-Spectrum Antibacterial Activity
Researchers from Children's Hospital, Boston report the development of a sensitive and robust but low-tech and inexpensive high-throughput metabolic screen for novel antibiotics.
News
Simcyp Limited Acquired by Certara
The acquisition makes Simcyp the third member of the Certara group alongside Tripos and Pharsight.
Advertisement